🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/04/2001 | 41,58 | 44,39 | 41,43 | 44,39 | +5,42% | 7,11% | 24.766 |
| 26/04/2001 | 41,14 | 42,52 | 40,05 | 42,11 | +2,37% | 6,01% | 37.911 |
| 25/04/2001 | 38,37 | 41,14 | 38,22 | 41,14 | +8,38% | 7,61% | 64.547 |
| 24/04/2001 | 38,93 | 39,68 | 37,92 | 37,95 | -3,52% | 4,52% | 34.197 |
| 23/04/2001 | 40,01 | 41,17 | 38,10 | 39,34 | -1,87% | 7,67% | 54.903 |
| 20/04/2001 | 43,31 | 43,79 | 40,05 | 40,09 | -8,07% | 8,64% | 104.329 |
| 19/04/2001 | 42,78 | 45,48 | 42,33 | 43,61 | +1,92% | 7,35% | 131.927 |
| 18/04/2001 | 44,13 | 46,75 | 42,45 | 42,78 | -1,12% | 9,75% | 111.943 |
| 17/04/2001 | 41,43 | 43,27 | 41,17 | 43,27 | +3,68% | 5,06% | 44.857 |
| 16/04/2001 | 39,30 | 42,48 | 39,30 | 41,73 | +3,72% | 8,10% | 39.300 |
| 12/04/2001 | 36,42 | 41,17 | 35,67 | 40,24 | +9,14% | 15,11% | 47.182 |
| 11/04/2001 | 36,49 | 39,30 | 36,49 | 36,87 | +0,20% | 7,69% | 98.371 |
| 10/04/2001 | 36,49 | 37,43 | 35,90 | 36,79 | +2,40% | 4,21% | 53.193 |
| 09/04/2001 | 34,21 | 35,93 | 33,39 | 35,93 | +8,94% | 7,44% | 46.434 |
| 06/04/2001 | 36,49 | 36,96 | 32,75 | 32,99 | -11,88% | 11,54% | 71.521 |
| 05/04/2001 | 34,86 | 37,43 | 34,86 | 37,43 | +5,26% | 7,38% | 84.398 |
| 04/04/2001 | 32,28 | 36,49 | 31,82 | 35,56 | +10,14% | 14,49% | 137.217 |
| 03/04/2001 | 36,49 | 38,25 | 30,18 | 32,28 | -6,44% | 22,12% | 128.320 |
| 02/04/2001 | 36,49 | 37,90 | 34,39 | 34,51 | -5,75% | 9,62% | 79.990 |
| 30/03/2001 | 34,74 | 37,43 | 33,92 | 36,61 | +5,03% | 10,10% | 86.161 |
| 29/03/2001 | 33,92 | 35,79 | 33,80 | 34,86 | -0,67% | 5,86% | 43.415 |
| 28/03/2001 | 35,44 | 36,03 | 33,69 | 35,09 | -0,99% | 6,60% | 38.846 |
| 27/03/2001 | 36,14 | 36,96 | 33,92 | 35,44 | -0,33% | 8,41% | 82.127 |
| 26/03/2001 | 36,14 | 39,77 | 33,45 | 35,56 | -3,49% | 17,48% | 86.802 |
| 23/03/2001 | 34,04 | 38,83 | 33,45 | 36,85 | +9,38% | 15,81% | 71.253 |
| 22/03/2001 | 34,62 | 34,86 | 29,24 | 33,69 | -2,04% | 16,22% | 114.641 |
| 21/03/2001 | 36,96 | 37,08 | 34,15 | 34,39 | -2,65% | 7,91% | 67.647 |
| 20/03/2001 | 38,37 | 40,70 | 34,62 | 35,32 | -5,62% | 15,85% | 86.696 |
| 19/03/2001 | 36,38 | 37,43 | 34,74 | 37,43 | +2,56% | 7,40% | 72.456 |
| 16/03/2001 | 37,43 | 37,90 | 36,49 | 36,49 | -3,11% | 3,75% | 63.372 |